Get Free Sample link @ https://www.omrglobal.com/request-sample/womens-health-diagnostics-market-size
During the COVID-19 pandemic, limited transportation options and travel restrictions created hurdles to international trade and transportation, which disrupted the supply chain for the women’s health diagnostics market, temporarily leading to a decline in demand due to uncertainty in the capital market and the global economy. The unfavorable changes in guidelines and regulations are impeding the growth of this sector. Major regulatory authorities have identified that breast cancer patients are at greater risk of COVID-19 infection than healthy adults. Thus, screening, surgical procedures, and diagnostic exams are being postponed and severely restricted at hospitals and breast cancer centers. According to an article in the JAMA Network in August 2020, there was a significant decline in breast cancer diagnoses by 51.8% in the US from March 2020 to April 2020. The delay in breast cancer diagnosis also impacted the treatment of the same, which is expected to disrupt the breast cancer treatment and diagnosis market.
A full report of Global Women Health Diagnostics Market available @ https://www.omrglobal.com/industry-reports/womens-health-diagnostics-market-size
• Market Coverage
• Market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered- By Source, By Product Type, By Applications
• Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Women Health Diagnostics Market by Application
o Breast Cancer Testing
o Cervical Cancer Testing
o Pregnancy & Fertility Testing
o Ovarian Cancer Testing
o Infectious Disease Testing
o Ultrasound Tests
o Sexually Transmitted Disease Testing
o Others (Osteoporosis Testing and Prenatal Genetic Testing)
Global Women Health Diagnostics Market by End-Users
o Diagnostic and Imaging Centers
o Hospitals and Clinics
o Home Care
Regional Analysis
o North America
o US
o Canada
o Europe
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe
o Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
o Rest of the World
Company Profiles
o Biomerieux SA
o DIALAB GmbH
o EKF Diagnostics Holdings PLC
o F. Hoffmann-La Roche Ltd.
o Fujifilm Holdings Corp.
o GenMark Diagnostics, Inc.
o Hologic, Inc.
o Koninklijke Philips N.V.
o Luminex Corp.
o Nova Biomedical Pte. Ltd.
o PerkinElmer Inc.
o QIAGEN N.V.
o Somagen Diagnostics Inc.
o Thermo Fisher Scientific Inc.
o Trinity Biotech PLC
The Report Covers
• Market value data analysis of 2021 and forecast to 2028.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global women health diagnostics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/womens-health-diagnostics-market-size
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404